Latest Insider Transactions at Clover Health Investments, Corp. (CLOV)
This section provides a real-time view of insider transactions for Clover Health Investments, Corp. (CLOV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CLOVER HEALTH INVESTMENTS, CORP. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CLOVER HEALTH INVESTMENTS, CORP. 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 07
2025
|
Vivek Garipalli Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,670,965
-54.25%
|
$5,012,895
$3.6 P/Share
|
|
Jan 07
2025
|
Vivek Garipalli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,670,965
+35.17%
|
-
|
|
Jan 07
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
17,142
-0.52%
|
$51,426
$3.6 P/Share
|
|
Jan 07
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,308
-0.31%
|
$12,924
$3.6 P/Share
|
|
Jan 06
2025
|
Carladenise Armbrister Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+11.41%
|
-
|
|
Jan 06
2025
|
Anna U Loengard Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+9.23%
|
-
|
|
Jan 06
2025
|
Thomas L Tran Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+37.72%
|
-
|
|
Jan 06
2025
|
William G Robinson Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+10.52%
|
-
|
|
Jan 06
2025
|
Chelsea Clinton Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+9.19%
|
-
|
|
Jan 06
2025
|
Lee Shapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+9.24%
|
-
|
|
Jan 06
2025
|
Demetrios L. Kouzoukas Director |
BUY
Grant, award, or other acquisition
|
Direct |
60,975
+10.38%
|
-
|
|
Jan 03
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,149
-0.24%
|
$24,447
$3.29 P/Share
|
|
Jan 01
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
278,765
-2.4%
|
$836,295
$3.15 P/Share
|
|
Dec 15
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,691
-0.26%
|
$26,073
$3.11 P/Share
|
|
Dec 15
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,391
-0.46%
|
$19,173
$3.11 P/Share
|
|
Dec 14
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
12,567
-0.37%
|
$37,701
$3.11 P/Share
|
|
Dec 14
2024
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
98,217
-2.83%
|
$294,651
$3.11 P/Share
|
|
Nov 14
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
7,444
-0.53%
|
$22,332
$3.08 P/Share
|
|
Nov 08
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,367
-0.73%
|
$256,101
$3.41 P/Share
|
|
Oct 31
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
152,040
-9.77%
|
$608,160
$4.12 P/Share
|
|
Oct 31
2024
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
111,496
-3.12%
|
$445,984
$4.12 P/Share
|
|
Oct 31
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
118,050
-3.4%
|
$472,200
$4.12 P/Share
|
|
Oct 31
2024
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
100,320
-3.78%
|
$401,280
$4.12 P/Share
|
|
Oct 18
2024
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
48,305
-1.79%
|
$193,220
$4.0 P/Share
|
|
Oct 15
2024
|
Andrew Toy Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,910,828
+14.03%
|
-
|
|
Oct 15
2024
|
Conrad Wai CEO, Counterpart Health |
BUY
Grant, award, or other acquisition
|
Direct |
726,114
+16.87%
|
-
|
|
Oct 15
2024
|
Brady Patrick Priest CEO of Home Care |
BUY
Grant, award, or other acquisition
|
Direct |
726,114
+21.2%
|
-
|
|
Oct 15
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
726,114
+17.3%
|
-
|
|
Oct 15
2024
|
Karen Soares General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
450,955
+22.47%
|
-
|
|
Oct 03
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,706
-0.32%
|
$34,824
$4.0 P/Share
|
|
Oct 01
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308,341
-3.05%
|
$616,682
$2.78 P/Share
|
|
Sep 15
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,691
-0.31%
|
$17,382
$2.99 P/Share
|
|
Sep 15
2024
|
Karen Soares General Counsel & Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,391
-0.57%
|
$12,782
$2.99 P/Share
|
|
Sep 14
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
12,567
-0.45%
|
$25,134
$2.99 P/Share
|
|
Sep 14
2024
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
98,217
-3.33%
|
$196,434
$2.99 P/Share
|
|
Sep 13
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
101,917
-3.54%
|
$203,834
$2.99 P/Share
|
|
Sep 13
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
BUY
Grant, award, or other acquisition
|
Direct |
259,000
+8.26%
|
-
|
|
Sep 13
2024
|
Karen Soares General Counsel & Secretary |
SELL
Sale (or disposition) back to the issuer
|
Direct |
117,340
-9.55%
|
$234,680
$2.99 P/Share
|
|
Sep 13
2024
|
Karen Soares General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
259,000
+17.41%
|
-
|
|
Sep 13
2024
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
93,180
-3.06%
|
$186,360
$2.99 P/Share
|
|
Sep 13
2024
|
Conrad Wai CEO, Counterpart Health |
BUY
Grant, award, or other acquisition
|
Direct |
189,934
+5.87%
|
-
|
|
Sep 13
2024
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
82,924
-4.03%
|
$165,848
$2.99 P/Share
|
|
Sep 13
2024
|
Brady Patrick Priest CEO of Home Care |
BUY
Grant, award, or other acquisition
|
Direct |
189,934
+8.46%
|
-
|
|
Aug 14
2024
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,241
-0.54%
|
$10,482
$2.51 P/Share
|
|
Aug 09
2024
|
Aric R Sharp CEO of Value Based Care |
SELL
Payment of exercise price or tax liability
|
Direct |
6,968
-0.33%
|
$6,968
$1.86 P/Share
|
|
Aug 09
2024
|
Vivek Garipalli Director |
BUY
Open market or private purchase
|
Direct |
531,700
+27.39%
|
$531,700
$1.88 P/Share
|
|
Aug 08
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,367
-0.84%
|
$85,367
$1.83 P/Share
|
|
Jul 18
2024
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
32,416
-1.71%
|
$32,416
$1.69 P/Share
|
|
Jul 03
2024
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
5,388
-0.21%
|
$5,388
$1.25 P/Share
|
|
Jul 01
2024
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308,341
-2.94%
|
$308,341
$1.2 P/Share
|